Silver Nanoparticles Induce a
Klebsiella pneumoniae
RNA sequencing
silver nanoparticles
soxS
triclosan
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
12
2020
accepted:
20
01
2021
entrez:
4
3
2021
pubmed:
5
3
2021
medline:
5
3
2021
Statut:
epublish
Résumé
Infections associated with antimicrobial-resistant bacteria now represent a significant threat to human health using conventional therapy, necessitating the development of alternate and more effective antibacterial compounds. Silver nanoparticles (Ag NPs) have been proposed as potential antimicrobial agents to combat infections. A complete understanding of their antimicrobial activity is required before these molecules can be used in therapy. Lysozyme coated Ag NPs were synthesized and characterized by TEM-EDS, XRD, UV-vis, FTIR spectroscopy, zeta potential, and oxidative potential assay. Biochemical assays and deep level transcriptional analysis using RNA sequencing were used to decipher how Ag NPs exert their antibacterial action against multi-drug resistant
Identifiants
pubmed: 33658987
doi: 10.3389/fmicb.2021.638640
pmc: PMC7917072
doi:
Types de publication
Journal Article
Langues
eng
Pagination
638640Informations de copyright
Copyright © 2021 Pareek, Devineau, Sivasankaran, Bhargava, Panwar, Srikumar and Fanning.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Microbiol Biotechnol. 2017 Apr 28;27(4):731-738
pubmed: 28081356
Methods Enzymol. 1978;52:302-10
pubmed: 672633
Front Microbiol. 2019 Feb 13;10:92
pubmed: 30814979
J Biol Inorg Chem. 2007 May;12(4):527-34
pubmed: 17353996
Nanoscale Res Lett. 2014 Oct 11;9(1):565
pubmed: 25435831
Microbiology (Reading). 2003 Sep;149(Pt 9):2397-2405
pubmed: 12949165
J Appl Microbiol. 2012 May;112(5):841-52
pubmed: 22324439
Nanomedicine. 2016 Apr;12(3):789-799
pubmed: 26724539
J Antimicrob Chemother. 2007 Apr;59(4):786-90
pubmed: 17307769
J Bacteriol. 2012 Oct;194(20):5495-503
pubmed: 22797754
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
J Biophotonics. 2018 May;11(5):e201700252
pubmed: 29243883
J Bacteriol. 2002 Mar;184(5):1474-80
pubmed: 11844783
Free Radic Biol Med. 1999 Sep;27(5-6):612-6
pubmed: 10490282
J Antimicrob Chemother. 2014 Mar;69(3):673-81
pubmed: 24176982
Oncotarget. 2018 Jan 4;9(5):6433-6449
pubmed: 29464083
Foodborne Pathog Dis. 2021 Feb;18(2):63-84
pubmed: 33124929
BMC Genomics. 2012 Dec 27;13:734
pubmed: 23270466
Biometals. 2013 Aug;26(4):609-21
pubmed: 23771576
Int J Antimicrob Agents. 2009 Oct;34(4):343-6
pubmed: 19615866
Biotechnol Adv. 2019 Jan - Feb;37(1):68-90
pubmed: 30471318
Clin Infect Dis. 2017 Apr 1;64(7):839-844
pubmed: 28013258
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12872-12877
pubmed: 30559200
Sci Rep. 2018 Jul 24;8(1):11131
pubmed: 30042429
Clin Microbiol Rev. 1998 Oct;11(4):589-603
pubmed: 9767057
Environ Pollut. 2017 Nov;230:125-133
pubmed: 28649040
Toxicol In Vitro. 2013 Mar;27(2):954-63
pubmed: 23357416
Nat Protoc. 2014 Aug;9(8):1771-91
pubmed: 24992094
Biometals. 2018 Dec;31(6):1101-1114
pubmed: 30284644
mBio. 2018 May 15;9(3):
pubmed: 29764953
Nanoscale Res Lett. 2014 Jul 26;9(1):365
pubmed: 25114655
J Antimicrob Chemother. 2008 Apr;61(4):869-76
pubmed: 18305203
Ann Clin Microbiol Antimicrob. 2012 Dec 13;11:32
pubmed: 23234297
ACS Nano. 2009 Apr 28;3(4):984-94
pubmed: 19344124
Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:739-749
pubmed: 29853145
J Nanobiotechnology. 2011 Aug 23;9:34
pubmed: 21859494
Biol Pharm Bull. 2005 Aug;28(8):1505-8
pubmed: 16079502
Nanomedicine (Lond). 2018 Jan;13(2):191-207
pubmed: 29199886
Nanotoxicology. 2012 Dec;6:857-66
pubmed: 22007647
Cell Rep. 2015 Aug 25;12(8):1289-99
pubmed: 26279566
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308
pubmed: 23458769
FEMS Microbiol Lett. 2013 Jul;344(2):159-65
pubmed: 23651393
Science. 1998 Mar 13;279(5357):1718-21
pubmed: 9497290
J Antimicrob Chemother. 2013 Jan;68(1):131-8
pubmed: 23011288
J Control Release. 2011 Dec 10;156(2):128-45
pubmed: 21763369
Front Microbiol. 2019 Apr 01;10:539
pubmed: 30988669
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31907190
Appl Environ Microbiol. 2010 Dec;76(24):7981-9
pubmed: 20952651
J Antimicrob Chemother. 2007 Apr;59(4):587-90
pubmed: 17307768
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13612-13617
pubmed: 27849602
J Antimicrob Chemother. 2019 Jun 1;74(6):1578-1585
pubmed: 30778552
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
J Med Microbiol. 1989 Jun;29(2):101-10
pubmed: 2659795
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Int J Nanomedicine. 2017 May 24;12:3941-3965
pubmed: 28579779
Genome Res. 2020 Feb;30(2):239-249
pubmed: 32051187
Future Microbiol. 2014;9(9):1071-81
pubmed: 25340836
J Antimicrob Chemother. 2017 Nov 1;72(11):3043-3046
pubmed: 28981647
J Antimicrob Chemother. 2015 Apr;70(4):1037-46
pubmed: 25567964
Front Microbiol. 2017 Oct 23;8:1913
pubmed: 29109700
Nanoscale. 2011 Feb;3(2):635-41
pubmed: 21088776
Chem Soc Rev. 2019 Jan 21;48(2):415-427
pubmed: 30462112
Surg Infect (Larchmt). 2009 Jun;10(3):289-92
pubmed: 19566416
ACS Appl Mater Interfaces. 2018 Sep 5;10(35):29325-29337
pubmed: 30096228
Environ Sci Technol. 2014;48(1):761-9
pubmed: 24328237
Adv Colloid Interface Sci. 2009 Jan 30;145(1-2):83-96
pubmed: 18945421
Angew Chem Int Ed Engl. 2013 Feb 4;52(6):1636-53
pubmed: 23255416
Diagn Microbiol Infect Dis. 2011 Apr;69(4):357-62
pubmed: 21396529